Based on the FY 2010 appropriation, the National Institute on Drug Abuse (NIDA) has established the following funding policy for non-ARRA related projects.

NIDA will continue to support the:


The FY 2010 average cost of competing grants is allowed to increase by 2% over FY 2009.

Non-Competing Continuations (Type 5)

  • All non-competing continuations (modular and non-modular) will be funded at 99% of committed levels, including co-funds. This policy does not apply to F's, T's, K's, SBIR/STTR and R13s. Future commitments will be adjusted accordingly.
  • Information regarding the NIH Fiscal Policy for Grant Awards - FY 2010 can be found at

New and Early Stage Investigators

Ruth L. Kirschstein National Research Service Awards (NRSA)

  • NIDA will support a 1% increase at all stipend levels